Amgen Inc Conference Call on the BeiGene Collaboration Transcript
My name is Laura, and I will be your conference facilitator today for Amgen's conference call. (Operator Instructions) I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.
Okay. Thank you, Laura. Good afternoon, everybody, and thanks for joining us on short notice. Our announcement today of a strategic collaboration in oncology with BeiGene is an important step in expanding our presence in China and towards advancing the development of our oncology pipeline globally.
To discuss the strategic rationale of this acquisition, our CEO, Bob Bradway, will make some opening comments; followed by David Meline, our CFO, who will discuss the anticipated financial impact of this collaboration. After David's comments, we'll open it up for questions.
And in addition to Bob, Murdo Gordon, our Head of Global Commercial Operations; and Dave Reese, our Head of R&D, will also join us for the Q&A session. So my customary reminder that some of the statements we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
